Co-Infection Completed Phase 2 Trials for Doxycycline (DB00254)

IndicationStatusPhase
DBCOND0075600 (Co-Infection)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02281643Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From GhanaPrevention